Nanotechnology News and Research

RSS
Celator, Cephalon extend cancer research agreement

Celator, Cephalon extend cancer research agreement

T2 Biosystems relocates to new 20,000 sq.ft. facility in Lexington

T2 Biosystems relocates to new 20,000 sq.ft. facility in Lexington

Iroko reports positive results from Phase I clinical study of nanotechnology based unique formulation of naproxen

Iroko reports positive results from Phase I clinical study of nanotechnology based unique formulation of naproxen

Five-stage reverse osmosis best for removal of hexavalent chromium from drinking water

Five-stage reverse osmosis best for removal of hexavalent chromium from drinking water

Gold nanoparticles show great potential for tumour targeted drug delivery

Gold nanoparticles show great potential for tumour targeted drug delivery

Nature News explores developing countries' commitment to R&D

Nature News explores developing countries' commitment to R&D

Biomagnification of nanomaterials in simple food chain demonstrated

Biomagnification of nanomaterials in simple food chain demonstrated

DNA tunneling detector embedded in a ‘Nanopore’

DNA tunneling detector embedded in a ‘Nanopore’

Arrowhead launches new company, Ablaris to commercialize novel weight loss technology

Arrowhead launches new company, Ablaris to commercialize novel weight loss technology

Celator granted U.S. Patent covering CombiPlex technology platform

Celator granted U.S. Patent covering CombiPlex technology platform

New nanotechnology based technique to detect pneumonia within minutes

New nanotechnology based technique to detect pneumonia within minutes

Fibrin microthreads support mesenchymal stem cell growth

Fibrin microthreads support mesenchymal stem cell growth

Audax Medical licenses novel TBL technology to fix broken bones from Brown

Audax Medical licenses novel TBL technology to fix broken bones from Brown

Shrink, EV Group enter development agreement for StemDisc stem cell and cell culturing platform

Shrink, EV Group enter development agreement for StemDisc stem cell and cell culturing platform

Positive data from Celator's CPX-351 Phase 2 study in newly-diagnosed AML presented at 52nd ASH

Positive data from Celator's CPX-351 Phase 2 study in newly-diagnosed AML presented at 52nd ASH

CSC's Leading Edge Forum: Disruptive technologies to reshape delivery of healthcare

CSC's Leading Edge Forum: Disruptive technologies to reshape delivery of healthcare

Marine life-inspired anti-microbial surfaces

Marine life-inspired anti-microbial surfaces

Appropriate level of Static Magnetic Field exposure for wound patients needs to be considered

Appropriate level of Static Magnetic Field exposure for wound patients needs to be considered

Shrink's MetalFluor technology on front cover of Applied Physics Letters

Shrink's MetalFluor technology on front cover of Applied Physics Letters

MU nanomedicine experts form new partnership with Shasun Pharmaceuticals

MU nanomedicine experts form new partnership with Shasun Pharmaceuticals

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.